Showing 711-720 of 4902 results for "".
- Nickel Reactions on the Rise. Diet to Blame?https://practicaldermatology.com/news/20120302-nickel_reactions_on_the_rise_diet_to_blame/2459857/Certain patients consuming healthy diets consisting of whole grains, legumes, nuts, and soy may be at increased risk of developing allergic reactions to nickel, according to dermatologist Matthew Zirwas, MD, an associate professor at
- The American Society for Laser Medicine and Surgery Names New Officershttps://practicaldermatology.com/news/the-american-society-for-laser-medicine-and-surgery-names-new-officers/2458185/The American Society for Laser Medicine and Surgery (ASLMS) introduced Mathew M. Avram, MD, JD, as its new President at the Annual Conference in April. Dr. Avram succeeds Kristen M. Kelly, MD, who now serves as the Society’s Past President. The 2017-18 ASLMS Executive Committee also i
- Editorial: Transferrable Loyalty and the State of Our Specialtyhttps://practicaldermatology.com/news/20140806-editorial_transferrable_loyalty_and_the_state_of_our_specialty/2459149/With the ongoing battle between Allergan and Valeant, it is evident that no practicing dermatologist can avoid concerns with the painful and tactical machinations. Long-term representatives have likely already changed their nametags from one company to another and are now pitching the same drugs und
- Treatment Sessions Linked to ABNOM Clearance in Laser Meta-Analysishttps://practicaldermatology.com/news/treatment-sessions-linked-to-abnom-clearance-in-laser-meta-analysis/2488080/Treatment session number was more strongly associated with clearance of acquired bilateral nevus of Ota-like macules (ABNOM) than whether patients received picosecond (PS) or Q-switched (QS) laser treatment, according to a new study. Published in Lasers in Medical Science, the ana
- GLP-1 Receptor Agonists Linked to Reduced Psoriasis Treatment Escalation in Type 2 Diabetics: Analysishttps://practicaldermatology.com/news/glp-1-receptor-agonists-linked-to-reduced-psoriasis-treatment-escalation-in-type-2-diabetics-analysis/2487939/Adults with psoriasis and type 2 diabetes mellitus (T2DM) treated with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) were less likely to require escalation of psoriasis therapy than patients receiving most other antihyperglycemic medications, according to
- Intermittent Daily Isotretinoin Matches Alternate-Day Regimen in Grade 2 Acne Trialhttps://practicaldermatology.com/news/intermittent-daily-isotretinoin-matches-alternate-day-regimen-in-grade-2-acne-trial/2487522/A randomized controlled trial published in the Indian Journal of Medical Research found that an intermittent daily isotretinoin regimen was non-inferior to a continuous alternate-day regimen for the treatment of grade 2 facial acne vulgaris, while also offering lower treatment costs.¹ Rese
- Maternal Type 2 Diabetes Not Linked to Reduced AD Risk in Children: Studyhttps://practicaldermatology.com/news/maternal-type-2-diabetes-not-linked-to-reduced-ad-risk-in-children-study/2487400/New research suggests maternal type 2 diabetes mellitus (T2DM) does not independently influence the risk of atopic dermatitis (AD) in children. Researchers for a retrospective cohort study analyzed electronic medical and birth records from Clalit Health Services in Israel (n = 314,224 moth
- Review: GLP-1 Receptor Agonists May Benefit Both Psoriasis and Metabolic Diseasehttps://practicaldermatology.com/news/review-glp-1-receptor-agonists-may-benefit-both-psoriasis-and-metabolic-disease/2487389/Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may offer additional benefits for patients with psoriasis, according to a new review and primer from the National Psoriasis Foundation Medical Board. The authors noted GLP-1 RAs have been associated with reductions in Psoriasis Area and
- New Grants Expand Teledermatology Access in the Bronx and Los Angeleshttps://practicaldermatology.com/news/new-gwpfizer-grants-expand-teledermatology-access-in-the-bronx-and-los-angeles/2486357/The George Washington University School of Medicine (GW) and Health Sciences, in collaboration with Pfizer Global Medical Grants, has awarded 2 new grants to expand teledermatology services in underserved US communities, with 2026 programs set for the Bronx and Los
- Dr. Jennifer Soung: Ask Patient’s Permission Before Talking GLP-1shttps://practicaldermatology.com/news/dr-jennifer-soung-ask-patients-permission-before-talking-glp-1s/2483863/GLP-1 treatments have become commonplace in dermatology practices, with both aesthetic and medical dermatology implications heavily involved. Talking to patients about the latter issue, however, can prove challenging. Despite the mounting literature indicating that GLP-1 agonists can help allevia